Treatment-resistant depression: therapeutic trends, challenges, and future directions

Al-harbi·2012·Patient Preference and Adherence
DOI 10.2147/ppa.s29716

Cited by (794)

Items 201–300 of 794

  1. Off-label use of transmucosal ketamine as a rapid-acting antidepressant: a retrospective chart review
    Rae R. Matsumoto, Linda Nguyen, Cory Weaver, K. Cramér, Scott Pollard, Patrick J. Marshalek · 2015 · Neuropsychiatric Disease and Treatment
  2. 7, 8-Dihydroxy-4-methylcoumarin reverses depression model-induced depression-like behaviors and alteration of dendritic spines in the mood circuits
    Mi Yang, Chang-Hao Luo, Yingqi Zhu, Yuanchu Liu, Ye-Juan An, Javed Iqbal, Zhezhi Wang, Xin‐Ming Ma · 2020 · Psychoneuroendocrinology
  3. Epidemiology of treatment resistant depression among major depressive disorder patients in Israel
    Sharman Moser, Sarah, Chodick, Gabriel, Gelerstein, Shulamit, Barit Ben David, Nava, Shalev, Varda, Stein-Reisner, Orit · 2022 · BMC Psychiatry
  4. Efficacy and Safety of Esketamine Nasal Spray in Patients with Treatment-Resistant Depression Who Completed a Second Induction Period: Analysis of the Ongoing SUSTAIN-3 Study
    Castro, Meredith, Wilkinson, Samuel T., Al Jurdi, Rayan K., Petrillo, Mary Pat, Zaki, Naim, Borentain, Stephane, Fu, Dong Jing, Turkoz, Ibrahim, Sun, Liping, Brown, Brianne et al. · 2023 · CNS Drugs
  5. Escin ameliorates CUMS-induced depressive-like behavior via BDNF/TrkB/CREB and TLR4/MyD88/NF-κB signaling pathways in rats
    Fengjiao Liu, Yaxin Jia, Liwei Zhao, L. Xiao, Xizhen Cheng, Xiao Yingying, Ying Zhang, Yuling Zhang, Huimin Yu, Qiao-en Deng et al. · 2024 · European Journal of Pharmacology
  6. Lower serum 25-hydroxycholecalciferol is associated with depressive symptoms in older adults in Southern Brazil
    Gilciane Ceolin, Luísa Harumi Matsuo, Susana Cararo Confortin, Eleonora d’Orsi, Débora Kurrle Rieger, Júlia Dübois Moreira · 2020 · Nutrition Journal
  7. Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain
    Elaine Meade, Sarah Hehir, Neil J. Rowan, Mary Garvey · 2022 · Journal of Fungi
  8. Ketamine as a rapid antidepressant: the debate and implications
    Roger Ho, Melvyn W. Zhang · 2016 · BJPsych Advances
  9. Resilience and Vulnerability to Stress-Induced Anhedonia: Unveiling Brain Gene Expression and Mitochondrial Dynamics in a Mouse Chronic Stress Depression Model
    Tatyana V. Strekalova, Evgeniy P. Svirin, Горлова Анна Вячеславовна, Elizaveta Sheveleva, Alisa Burova, A. H. Khairetdinova, Kseniia Sitdikova, Elena Zakharova, Alexander M. Dudchenko, Aleksey V. Lyundup et al. · 2023 · Biomolecules
  10. Drug metabolizing enzymes pharmacogenetic variation-informed antidepressant therapy approach for common mental disorders: A systematic review and meta-analysis
    Santenna Chenchula, Atal Shubham, Ratinder Jhaj, Abhijit Ramdas Rozatkar, Tamonud Modak, Singh Jitendra, Muhammad Aaqib Shamim, S Balakrishnan · 2024 · Journal of Affective Disorders
  11. Ketamine’s potential as a rapid antidepressant was overplayed
    Melvyn Weibin Zhang, Roger Ho · 2015 · BMJ
  12. Efficacy of amisulpride for depressive symptoms in individuals with mental disorders: A systematic review and meta‐analysis
    Caroline Zangani, Barbara Giordano, Hans‐Christian Stein, Stefano Bonora, Armando D’Agostino, Edoardo Giuseppe Ostinelli · 2021 · Human Psychopharmacology Clinical and Experimental
  13. Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies
    Richard L. Doty, Vanina Popova, Crystal Wylie, Maggie M Fedgchin, Ella Daly, Adam Janik, Rachel Ochs-Ross, Rosanne Lane, Pilar Lim, Kim L. Cooper et al. · 2021 · CNS Drugs
  14. Machine Learning Based Evaluations of Stress, Depression, and Anxiety
    Naresh Kumar Trivedi, Raj Gaurang Tiwari, Deden Witarsyah, Vinay Gautam, Alok Misra, Ryan Adhitya Nugraha · 2022 · International Conference on Advancement in Data Science, E-learning and Information System (ICADEIS)
  15. Bifrontal-transcranial direct current stimulation as an early augmentation strategy in major depressive disorder: A single-blind randomised controlled trial
    Babli Kumari, Amit Kumar Singh, Sujita Kumar Kar, Adarsh Tripathi, Vivek Agarwal · 2023 · Asian Journal of Psychiatry
  16. Psychedelic-assisted therapies: The past, and the need to move forward responsibly
    John Gardner, Adrian Carter, Kerry O’Brien, Kate Seear · 2019 · International Journal of Drug Policy
  17. Brain Plasma Membrane Monoamine Transporter in Health and Disease
    Letícia Salvador Vieira, Joanne Wang · 2021 · Handbook of experimental pharmacology
  18. Benefits of group compassion-focused therapy for treatment-resistant depression: A pilot randomized controlled trial
    K. Asano, M. Tsuchiya, Y. Okamoto, Toshiyuki Ohtani, Toshihiko Sensui, A. Masuyama, Ayako Isato, M. Shoji, Tetsuya Shiraishi, E. Shimizu et al. · 2022 · Frontiers in Psychology
  19. B cells and the stressed brain: emerging evidence of neuroimmune interactions in the context of psychosocial stress and major depression
    Elizabeth B. Engler-Chiurazzi · 2024 · Frontiers in Cellular Neuroscience
  20. Non-pharmacological and pharmacological approaches for psychiatric disorders: Re-appraisal and insights from zebrafish models
    Murilo S. de Abreu, Ana C.V.V. Giacomini, Rafael Genário, Nathália Rech, Júlia Carboni, Anton M. Lakstygal, Tamara G. Amstislavskaya, Konstantin A. Demin, Brian E. Leonard, Marli Vlok et al. · 2020 · Pharmacology Biochemistry and Behavior
  21. Sex-Based Impact of Creatine Supplementation on Depressive Symptoms, Brain Serotonin and SSRI Efficacy in an Animal Model of Treatment-Resistant Depression
    Shami Kanekar, Robert Ettaro, Michael D. Hoffman, Hendrik J. Ombach, Jadeda Brown, Cayla J. Lynch, Chandni S. Sheth, Perry Franklin Renshaw · 2021 · International Journal of Molecular Sciences
  22. Serotonin Receptor and Transporter Endocytosis Is an Important Factor in the Cellular Basis of Depression and Anxiety
    Nikita Deo, Gregory Redpath · 2022 · Frontiers in Cellular Neuroscience
  23. Serum Cortisol, Nesfatin-1, and IL-1β: Potential Diagnostic Biomarkers in Elderly Patients with Treatment-Resistant Depression
    Xiaoping Wu, Biao Dai, Fanfan Yan, Yang Chen, Yayun Xu, Qingrong Xia, Xulai Zhang · 2022 · Clinical Interventions in Aging
  24. Xiaoyaosan inhibits neuronal apoptosis by regulating the miR-200/NR3C1 signaling in the prefrontal cortex of chronically stressed rats
    Naijun Yuan, Xiaojuan Li, Kairui Tang, Hua Tian Gan, Xiaoli Da, Wenzhi Hao, Lijuan Deng, Junqing Huang, Qingyu Ma, Man-Si Wu et al. · 2022 · Phytomedicine
  25. The recent development of topical nanoparticles for annihilating skin cancer
    Dnyanesh Saindane, Sankha Bhattacharya, Rahul K. Shah, Bhupendra Gopalbhai Prajapati · 2022 · All Life
  26. The impact of digital interventions on medication adherence in paediatric populations with attention deficit hyperactivity disorder, depression, and/or anxiety: A rapid systematic review and meta-analysis
    Astrit Vitija, Amirthan Rajakumaran Selliah Amirthalingam, Abderrezzaq Soltani · 2022 · Research in Social and Administrative Pharmacy
  27. Long-term symptomatic and functional outcome following an intensive inpatient multidisciplinary intervention for treatment-resistant affective disorders
    Wooderson, Sarah C., Fekadu, Abebaw, Markopoulou, Kalypso, Rane, Lena J., Poon, Lucia, Juruena, Mario F., Strawbridge, Rebecca, Cleare, Anthony J. · 2014 · Journal of Affective Disorders
  28. Opioid system modulators buprenorphine and samidorphan alter behavior and extracellular neurotransmitter concentrations in the Wistar Kyoto rat
    Karen L. Smith, Jacobi I. Cunningham, David J. Eyerman, Reginald L. Dean, Daniel R. Deaver, Connie Sánchez · 2018 · Neuropharmacology
  29. Increased ventromedial prefrontal cortex activity and connectivity predict poor sertraline treatment outcome in late‐life depression
    Hadeer Emam, David C. Steffens, Godfrey D. Pearlson, Lihong Wang · 2019 · International Journal of Geriatric Psychiatry
  30. Phosphodiesterase-5 inhibitors: Shedding new light on the darkness of depression?
    Eduardo Pereira Duarte-Silva, Adriano José Maia Chaves Filho, Tatiana Barichello, João Quevedo, Danielle S. Macêdo, Christina Alves Peixoto · 2019 · Journal of Affective Disorders
  31. Deep Brain Stimulation for Refractory Depression, Obsessive-Compulsive Disorder and Addiction
    Ali R. Rezai, Manish Ranjan, Nutan Ranjan, Milind S. Deogaonkar · 2020 · Neurology India
  32. The Effect of Chronic Mild Stress and Escitalopram on the Expression and Methylation Levels of Genes Involved in the Oxidative and Nitrosative Stresses as Well as Tryptophan Catabolites Pathway in the Blood and Brain Structures
    Paulina Wigner, Ewelina Synowiec, Paweł Jóźwiak, Piotr Lech Czarny, Michał Bijak, Katarzyna I. Białek, Janusz Szemraj, Piotr Gruca, Mariusz Papp, Tomasz Śliwiński · 2020 · International Journal of Molecular Sciences
  33. Perspective—Electrochemical Sensors for Neurotransmitters and Psychiatrics: Steps toward Physiological Mental Health Monitoring
    Marjon Zamani, Tatum Wilhelm, Ariel L. Furst · 2022 · Journal of The Electrochemical Society
  34. In-silico EEG biomarkers of reduced inhibition in human cortical microcircuits in depression
    Frank Mazza, Alexandre Guet-McCreight, Taufik A. Valiante, John David Griffiths, Etay Hay · 2023 · PLoS Computational Biology
  35. Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
    Bradley Roberts, Zahra Cooper, Stephanie Y. Lu, Susanne H. Stanley, Bernadette T. Majda, Khan R. L. Collins, Lucy Gilkes, Jennifer Rodger, Patrick Anthony Akkari, Sean D. Hood · 2023 · Frontiers in Pharmacology
  36. Sequencing the serotonergic neuron translatome reveals a new role for Fkbp5 in stress
    Atom J. Lesiak, Kevin R. Coffey, Joshua H. Cohen, Katharine J. Liang, Charles Chavkin, John F. Neumaier · 2020 · Molecular Psychiatry
  37. Using prefrontal and midline right frontal EEG-derived theta cordance and depressive symptoms to predict the differential response or remission to antidepressant treatment in major depressive disorder
    Sara de la Salle, Natalia Jaworska, Pierre Blier, Dylan Smith, Verner Knott · 2020 · Psychiatry Research Neuroimaging
  38. Exosomes: A Novel Therapeutic Paradigm for the Treatment of Depression
    Shvetank Bhatt, Jovita Kanoujia, Arghya Kusum Dhar, Surendar Arumugam, Amanda Silva, Neeraj Mishra · 2020 · Current Drug Targets
  39. Phloridzin ameliorates type 2 diabetes‐induced depression in mice by mitigating oxidative stress and modulating brain‐derived neurotrophic factor
    Sandesh P. Kamdi, Amit Raval, Kartik Tularam Nakhate · 2021 · Journal of Diabetes & Metabolic Disorders
  40. Associations Between Antidepressant Use and Advanced Diabetes Outcomes in Patients with Depression and Diabetes Mellitus
    Chi‐Shin Wu, Le‐Yin Hsu, Yi‐Jiun Pan, Shi‐Heng Wang · 2021 · The Journal of Clinical Endocrinology & Metabolism
  41. Estrogen, the Peripheral Immune System and Major Depression – A Reproductive Lifespan Perspective
    Elizabeth B. Engler-Chiurazzi, Wesley H. Chastain, Kailen K. Citron, Lillian E. Lambert, Divya N. Kikkeri, Sharhana S. Shrestha · 2022 · Frontiers in Behavioral Neuroscience
  42. Preclinical models of treatment-resistant depression: challenges and perspectives
    Magdalena Kolasa, Agata Faron‐Górecka · 2023 · Pharmacological Reports
  43. TAARs as Novel Therapeutic Targets for the Treatment of Depression: A Narrative Review of the Interconnection with Monoamines and Adult Neurogenesis
    Taisiia S. Shemiakova, Evgeniya V. Efimova, Raul R. Gainetdinov · 2024 · Biomedicines
  44. A meta-analysis of the potential antidepressant effects of buprenorphine versus placebo as an adjunctive pharmacotherapy for treatment-resistant depression
    Adam Dinoff, Sean T. Lynch, Nitin K Sekhri, Lidia Klepacz · 2020 · Journal of Affective Disorders
  45. A single administration of the antibiotic, minocycline, reduces fear processing and improves implicit learning in healthy volunteers: analysis of the serum metabolome
    Shi Yu Chan, Liliana P. Capitão, Fay Probert, Corinna Klinge, Sebastian Höckner, Catherine J. Harmer, Philip J. Cowen, Daniel C. Anthony, Philip W. J. Burnet · 2020 · Translational Psychiatry
  46. Post-weaning Social Isolated Flinders Sensitive Line Rats Display Bio-Behavioural Manifestations Resistant to Fluoxetine: A Model of Treatment-Resistant Depression
    Khulekani Mncube, Marisa Möller, Brian Herbert Harvey · 2021 · Frontiers in Psychiatry
  47. Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study
    Eduard Vieta, Nahida Ahmed, Celso Arango, Anthony James Cleare, Koen Demyttenaere, Markus Dold, Tetsuro Ito, Yerkebulan Kambarov, Stephanie Krüger, Pierre‐Michel Llorca et al. · 2025 · European Neuropsychopharmacology
  48. Neuroinflammation and Neurotransmission Mechanisms Involved in Neuropsychiatric Disorders
    Jacqueline Alves Leite, Ana Maria Orellana, Paula Fernanda Kinoshita, Natália Prudente de Mello, Cristóforo Scavone, Elisa Mitiko Kawamoto · 2017 · InTech eBooks
  49. Current Perspectives on Pharmacological and Non-Pharmacological Interventions for the Inflammatory Mechanism of Unipolar Depression
    Ioana-Alexandra Dogaru, Maria Gabriela Puiu, Mirela Manea, Vlad Dionisie · 2022 · Brain Sciences
  50. Phosphatidylinositol 4,5-bisphosphate (PIP2) facilitates norepinephrine transporter dimerization and modulates substrate efflux
    Dino Luethi, Julian Maier, Deborah Rudin, Dániel Szöllősi, Thomas J. F. Angenoorth, Stevan Stankovic, Matthias Schittmayer, Isabella Burger, Jae‐Won Yang, Kathrin Jäntsch et al. · 2022 · Communications Biology
  51. “It’s about What You’ve Assigned to the Salad”: Focus Group Discussions on the Relationship between Food and Mood
    Megan Frances Lee, Joanne Bradbury, Jacqui Yoxall, Sally J. E. Sargeant · 2023 · International Journal of Environmental Research and Public Health
  52. Knowledge and attitudes on medication adherence and residual symptoms in individuals with depression: a survey at a University Hospital
    Jarurin Pitanupong, Jakkapon Sammathit · 2023 · BMC Psychiatry
  53. Neurometabolite changes in response to antidepressant medication: A systematic review of 1H-MRS findings
    Daphne E. Boucherie, Liesbeth Reneman, Henricus Gerardus Ruhé, Anouk Schrantee · 2023 · NeuroImage Clinical
  54. Antidepressant-like Effect of Oroxylum indicum Seed Extract in Mice Model of Unpredictable Chronic Mild Stress
    Chorpeth Chalermwongkul, Charinya Khamphukdee, Juthamart Maneenet, Supawadee Daodee, Orawan Monthakantirat, Chantana Boonyarat, Yutthana Chotritthirong, Suresh Awale, Anake Kijjoa, Yaowared Chulikhit · 2023 · Nutrients
  55. Lateral hypothalamus orexinergic projection to the medial prefrontal cortex modulates chronic stress-induced anhedonia but not anxiety and despair
    Danlei Liu, Xuefeng Zheng, Yuqing Hui, Yuanyuan Xu, Jinjiang Du, Zean Du, Yichen Che, Fengming Wu, Guangyin Yu, Jifeng Zhang et al. · 2024 · Translational Psychiatry
  56. Depression clinical trials worldwide: a systematic analysis of the ICTRP and comparison with ClinicalTrials.gov
    Eugenia D. Namiot, Diana Smirnovová, Aleksandr V. Sokolov, Vladimir N. Chubarev, Vadim V. Tarasov, Helgi B. Schiöth · 2024 · Translational Psychiatry
  57. Therapeutic doses of antidepressants are projected not to inhibit human α4β2 nicotinic acetylcholine receptors
    Mark L. Weber, Corry M. Hofland, Christopher L. Shaffer, Gunnar Flik, Thomas I.F.H. Cremers, Raymond S Hurst, Hans Rollema · 2013 · Neuropharmacology
  58. Polygala japonica Houtt. reverses depression-like behavior and restores reduced hippocampal neurogenesis in chronic stress mice
    Yu Zhou, Chaolin Ma, Bao‐Ming Li, Chong Sun · 2018 · Biomedicine & Pharmacotherapy
  59. Ketamine ameliorates severe traumatic event-induced antidepressant-resistant depression in a rat model through ERK activation
    C.J. Lee, Yi–Ju Chen, Han-Fang Wu, Yueh-Jung Chung, Yi‐Chao Lee, Cheng‐Ta Li, Hui‐Ching Lin · 2019 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  60. American Gun Violence & Mental Illness: Reducing Risk, Restoring Health, Respecting Rights & Reviving Communities
    Jeffrey W. Swanson, Mark L. Rosenberg · 2023 · Daedalus
  61. Biomarkers in the Diagnosis and Prediction of Medication Response in Depression and the Role of Nutraceuticals
    Cristina Beer, Fiona Rae, Annalese Semmler, Joanne Voisey · 2024 · International Journal of Molecular Sciences
  62. Kir4.1 Dysfunction in the Pathophysiology of Depression: A Systematic Review
    Stefania Della Vecchia, Maria Marchese, Filippo Maria Santorelli, Federico Sicca · 2021 · Cells
  63. Evaluation of Individual Items of the Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) in Adults with Treatment-Resistant Depression Treated with Esketamine Nasal Spray Combined with a New Oral Antidepressant
    Lysbeth L. Floden, Stacie A. Hudgens, Carol Jamieson, Vanina Popova, Wayne Curtis Drevets, Kimberly Cooper, Jaskaran B. Singh · 2022 · CNS Drugs
  64. Basal Forebrain Cholinergic Innervation Induces Depression-Like Behaviors Through Ventral Subiculum Hyperactivation
    Nana Yu, Huina Song, Guangpin Chu, Xu Zhan, Bo Liu, Yangling Mu, Jian‐Zhi Wang, Yisheng Lu · 2022 · Neuroscience Bulletin
  65. Efficacy and Safety of Esketamine Combined with Antidepressants for Treatment-Resistant Depression: A Meta-Analysis
    Peng Liu, Shanshan Zhang, Yun Liang, Zijun Gao, Wei Gao, Buhuai Dong · 2022 · Neuropsychiatric Disease and Treatment
  66. Cortisol as a Target for Treating Mental Disorders: A Promising Avenue for Therapy
    Vijay K. Patel, Aayush Vaishnaw, Ekta Shirbhate, Rakesh Kore, Vaibhav Pratap Singh, Ravichandran Veerasamy, Harish Rajak · 2023 · Mini-Reviews in Medicinal Chemistry
  67. Green synthesis of gold nanoparticles from the extract of Crocus sativus to study the effect of antidepressant in adolescence and to observe its aggressive and impulsive behavior in rat models
    Renjiao Li, Xi Chen, Haisen Ye, Xia Sheng · 2024 · South African Journal of Botany
  68. Neurosurgical neuromodulation therapy for psychiatric disorders
    Manish Ranjan, James Joseph Mahoney, Ali R. Rezai · 2024 · Neurotherapeutics
  69. Targeted drug release from stable and safe ultrasound-sensitive nanocarriers
    Matthew G. Wilson, Aarav Parikh, Audri Dara, Alexander S. Beaver, Jan Kubanek · 2024 · Frontiers in Molecular Biosciences
  70. HBK-7 — A new xanthone derivative and a 5-HT1A receptor antagonist with antidepressant-like properties
    Karolina Pytka, Grzegorz Kazek, Agata Siwek, Barbara Mordyl, Monika Głuch‐Lutwin, Anna Rapacz, Adrian Olczyk, Adam Gałuszka, Anna Maria Waszkielewicz, Henryk Marona et al. · 2016 · Pharmacology Biochemistry and Behavior
  71. Emotion Regulation Protects Against Recurrence of Depressive Symptoms Following Inpatient Care for Major Depressive Disorder
    David Daniel Ebert, Lisa Hopfinger, Claudi Bockting, Matthias Berking · 2017 · Behavior Therapy
  72. Nicotine Rescues Depressive-like Behaviors via α7-type Nicotinic Acetylcholine Receptor Activation in CaMKIV Null Mice
    Shigeki Moriguchi, Ryo Inagaki, Lusha Yi, Mikako Shibata, Hiroyuki Sakagami, Kohji Fukunaga · 2020 · Molecular Neurobiology
  73. A Retrospective Naturalistic Study Comparing the Efficacy of Ketamine and Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression
    Georgios Mikellides, Panayiota Michael, Lilia Psalta, Teresa Schuhmann, Alexander Thomas Sack · 2022 · Frontiers in Psychiatry
  74. Magnitude of Reduction and Speed of Remission of Suicidality for Low Amplitude Seizure Therapy (LAP-ST) Compared to Standard Right Unilateral Electroconvulsive Therapy: A Pilot Double-Blinded Randomized Clinical Trial
    Nagy A. Youssef, Dheeraj Ravilla, Cherishma Patel, Mark Yassa, Ramses Sadek, Li Fang Zhang, Laryssa McCloud, William Vaughn McCall, Peter B. Rosenquist · 2019 · Brain Sciences
  75. Molecular Mechanisms Associated with Antidepressant Treatment on Major Depression
    Lívia Ramos-da-Silva, Pamela T. Carlson, Lícia C. Silva-Costa, Daniel Martins‐de‐Souza, Valéria de Almeida · 2021 · Complex Psychiatry
  76. The cost-effectiveness of depression screening for the general adult population
    Melike Yildirim, Bradley Neil Gaynes, Pınar Keskinocak, Brian Wells Pence, Julie Swann · 2022 · Journal of Affective Disorders
  77. A review of potential neuropathological changes associated with ketamine
    Danica Nogo, Hana Nazal, Yuetong Song, Kayla M. Teopiz, Roger Ho, Roger S. McIntyre, Leanna M.W. Lui, Joshua Daniel Rosenblat · 2022 · Expert Opinion on Drug Safety
  78. Remus: System for remote deep brain interventions
    Taylor D. Webb, Matthew G. Wilson, Henrik Odéen, Jan Kubanek · 2022 · iScience
  79. Just a gut feeling: Faecal microbiota transplant for treatment of depression – A mini-review
    Minna Chang, Kai Tuomas Chang, Fuju Chang · 2024 · Journal of Psychopharmacology
  80. Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges
    Anton Gomez-Escolar, Daniel Folch‐Sanchez, Joanna Stefaniuk, Zoe Swithenbank, Andreia Nisa, Fleur Braddick, Nazish Idrees Chaudhary, Pim B. van der Meer, Albert Batalla · 2024 · CNS Drugs
  81. Astrogliosis Associated With Behavioral Abnormality in a Non-anaphylactic Mouse Model of Cow's Milk Allergy
    Nicholas A. Smith, Danielle L. Germundson, Colin Kelly Combs, Lane P. Vendsel, Kumi Nagamoto‐Combs · 2019 · Frontiers in Cellular Neuroscience
  82. The relationship between depressive symptoms, general psychopathology, and well‐being in patients with major depressive disorder
    Annelies Weijers, Sanne P. A. Rasing, Daan H. M. Creemers, Ad A. Vermulst, Arnt Schellekens, Gerben J. Westerhof · 2020 · Journal of Clinical Psychology
  83. Histone Lysine Demethylase JMJD2D/KDM4D and Family Members Mediate Effects of Chronic Social Defeat Stress on Mouse Hippocampal Neurogenesis and Mood Disorders
    S. Maitra, N. Khandelwal, S. Kootar, Pooja Sant, S. S. Pathak, Sujatha Reddy, Annapoorna P. K., U. Murty, S. Chakravarty, Arvind Kumar · 2020 · Brain Science
  84. Real‐world treatment patterns, outcomes, resource utilization and costs in treatment‐resistant major depressive disorder: PATTERN, a retrospective cohort study in Belgium
    Gillain, B., Degraeve, G., Dreesen, T., De Bruecker, G., Buntinx, E., Beke, D., Kestens, C., Valassopoulou, E., Verhelst, F., Peeters, E. et al. · 2022 · PharmacoEconomics - Open
  85. Biomarkers for Deep Brain Stimulation in Animal Models of Depression
    Jason Yuen, Aaron E. Rusheen, J. Blair Price, Abhijeet S. Barath, Hojin Shin, Abbas Z. Kouzani, Michael Berk, Charles D. Blaha, Kendall H. Lee, Yoonbae Oh · 2021 · Neuromodulation Technology at the Neural Interface
  86. Effects of escitalopram therapy on functional brain controllability in major depressive disorder
    Feng Zhou Fang, Beata R. Godlewska, Raymond Y. Cho, Sean Isaac Savitz, Sudhakar Selvaraj, Yingchun Zhang · 2022 · Journal of Affective Disorders
  87. Chronic clomipramine treatment increases hippocampal volume in rats exposed to chronic unpredictable mild stress
    Shanshan Zhang, Juntao Hu, Guixue Liu, Haoran Wu, Meihui Li, Chenye Shi, Qiong Liu, Wensheng Li · 2022 · Translational Psychiatry
  88. Recent Advances in the Development of Antidepressants Targeting the Purinergic P2X7 Receptor
    Shin‐Young Lee, Hyunsoo Ha, Jaebong Jang, Youngjoo Byun · 2022 · Current Medicinal Chemistry
  89. Challenges and prospects in bridging precision medicine and artificial intelligence in genomic psychiatric treatment
    Uchenna Esther Okpete, Haewon Byeon · 2024 · World Journal of Psychiatry
  90. New use for an old drug: oral ketamine for treatment-resistant depression
    Kevin Swiatek, Kim M. Jordan, Julie H Coffman · 2016 · BMJ Case Reports
  91. A Close Look at Echium amoenum Processing, Neuroactive Components, and Effects on Neuropsychiatric Disorders
    Mohammad Nouri, Fereshteh Farajdokht, Mohammadali Torbati, Fatemeh Ranjbar Kuchaksaray, Sanaz Hamedyazdan, Mostafa Araj‐Khodaei, Saeed Sadigh‐Eteghad · 2019 · Galen Medical Journal
  92. Cost-utility analysis of esketamine and electroconvulsive therapy in adults with treatment-resistant depression
    Kinza Degerlund Maldi, Peter Asellus, Anna Myléus, Fredrik Norström · 2021 · BMC Psychiatry
  93. From antioxidant to neuromodulator: The role of ascorbate in the management of major depression disorder
    Nuno R. Ferreira, Carla Vitorino, Ana C. Fortuna · 2022 · Biochemical Pharmacology
  94. Perspectives of a pharmacist‐run pharmacogenomic service for depression in interdisciplinary family medicine practices
    Sara Weinstein, Joni C. Carroll, Sejla Jukic, Melissa Somma McGivney, Patricia M. Klatt · 2019 · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY
  95. Vitamin D and N-Acetyl Cysteine Supplementation in Treatment-Resistant Depressive Disorder Patients: A General Review
    Flavia di Michele, Alessandra Talamo, Cinzia Niolu, Alberto Siracusano · 2020 · Current Pharmaceutical Design
  96. Ethanol-Induced Depression: Exploring the Underlying Molecular Mechanisms
    Habibeh Mashayekhi‐Sardoo, Fateme Razazpour, Zohreh Hakemi, Mahdiyeh Hedayati‐Moghadam, Yousef Baghcheghi · 2025 · Cellular and Molecular Neurobiology
  97. Modeling neurodevelopmental and psychiatric diseases with human iPSCs
    Zhexing Wen · 2017 · Journal of Neuroscience Research
  98. Changes in healthcare resource use and costs associated with early versus delayed initiation of atypical antipsychotic adjunctive treatment in major depressive disorder
    Arpamas Seetasith, Mallik Greene, Ann Hartry, Chakkarin Burudpakdee · 2018 · Journal of Medical Economics
  99. The Effects of Focal Electrically Administered Seizure Therapy Compared With Ultrabrief Pulse Right Unilateral Electroconvulsive Therapy on Suicidal Ideation
    Nagy A. Youssef, Mark S. George, William Vaughn McCall, Gregory L. Sahlem, Baron Short, Suzanne Kerns, Andrew J. Manett, James B. Fox, Morgan M. Dancy, Daniel N. Cook et al. · 2021 · Journal of Ect
  100. Serum Mature BDNF Level Is Associated with Remission Following ECT in Treatment-Resistant Depression
    Marion Psomiades, Marine Mondino, Filipe Galvão, Nathalie Mandairon, Mikaïl Nourredine, Marie‐Françoise Suaud‐Chagny, Jérôme Brunelin · 2022 · Brain Sciences